Needle Selection Strategy for EUS-Guided Tissue Acquisition Using 22-Gauge Needles in Small Pancreatic Solid Lesions
Abstract
Objective To evaluate the needle selection process for endoscopic ultrasound-guided tissue acquisition (EUS-TA) using 22-gauge needles in pancreatic solid lesions ≤20 mm. Methods Consecutive patients with pancreatic solid lesions ≤20 mm who underwent EUS-TA were retrospectively reviewed at a referral center. Only procedures that used 22-gauge needles were included. The overall diagnostic accuracy was compared between the fine-needle aspiration (FNA) and fine-needle biopsy (FNB) groups. Multivariable logistic regression and propensity score-matched analyses were performed. Patients or Materials A total of 348 patients with pancreatic solid lesions ≤20 mm were included (FNA, n=193; FNB, n=155). Results No statistically significant difference in the overall diagnostic accuracy was observed between the FNA and FNB groups (92.7% vs. 95.5%, p=0.27). The median number of needle passes was lower in the FNB group (2 vs. 3, p<0.001), and the histological yield was higher (92.9% vs. 84.5%, p=0.019). The needle type was not independently associated with diagnostic accuracy (OR 1.76, 95% CI 0.69-4.52; p=0.24). In lesions measuring ≤10 mm, subgroup analysis was limited by the small sample size of the study. The rarly adverse event rates were low in both groups. Conclusion In pancreatic solid lesions ≤20 mm, FNB showed a higher histological yield and required fewer needle passes, whereas no significant difference in the diagnostic accuracy was observed between FNA and FNB. Therefore, the routine replacement of FNA with FNB may not be justified when benign-malignant differentiation is sufficient. FNB may be preferable when histological architecture or immunohistochemical evaluation is required and is considered technically feasible.
Related
- Macroscopic Tissue Integrity and Histological Diagnostic Yield During Endoscopic Ultrasound-Guided Tissue Acquisition for Solid Pancreatic Lesions
- Strategy for early diagnosis of pancreatic cancer
- Macroscopic versus rapid on-site evaluation for EUS-guided tissue acquisition of solid pancreatic masses: a systematic review, diagnostic test accuracy meta-analysis, and network meta-analysis
- Integrated single-cell and proteomic profiling of pancreatic neoplasia identifies tissue markers that outperform established diagnostic markers in distinguishing cancer from precursor lesions.
- Multimodal preoperative risk stratification of pancreatic mass lesions using clinical variables, imaging radiomics and plasma cfDNA methylation: protocol for an ambispective multicentre diagnostic prediction model study
BibTeX
@article{fujita2026needle,
title = {{Needle Selection Strategy for EUS-Guided Tissue Acquisition Using 22-Gauge Needles in Small Pancreatic Solid Lesions}},
author = {Akashi Fujita and Shomei Ryozawa and Masafumi Mizuide and Yuki Tanisaka and Suguru Ito and Ryuichi Watanabe and Ryosuke Hamamura and Yoshiki Matsuno},
journal = {Internal Medicine},
year = {2026},
month = jul,
doi = {10.2169/internalmedicine.7638-26},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7638-26/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Needle Selection Strategy for EUS-Guided Tissue Acquisition Using 22-Gauge Needles in Small Pancreatic Solid Lesions
AU - Akashi Fujita
AU - Shomei Ryozawa
AU - Masafumi Mizuide
AU - Yuki Tanisaka
AU - Suguru Ito
AU - Ryuichi Watanabe
AU - Ryosuke Hamamura
AU - Yoshiki Matsuno
PY - 2026
DA - 2026/07/11
JO - Internal Medicine
DO - 10.2169/internalmedicine.7638-26
UR - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7638-26/_article
AB - Objective To evaluate the needle selection process for endoscopic ultrasound-guided tissue acquisition (EUS-TA) using 22-gauge needles in pancreatic solid lesions ≤20 mm. Methods Consecutive patients with pancreatic solid lesions ≤20 mm who underwent EUS-TA were retrospectively reviewed at a referral center. Only procedures that used 22-gauge needles were included. The overall diagnostic accuracy was compared between the fine-needle aspiration (FNA) and fine-needle biopsy (FNB) groups. Multivariable logistic regression and propensity score-matched analyses were performed. Patients or Materials A total of 348 patients with pancreatic solid lesions ≤20 mm were included (FNA, n=193; FNB, n=155). Results No statistically significant difference in the overall diagnostic accuracy was observed between the FNA and FNB groups (92.7% vs. 95.5%, p=0.27). The median number of needle passes was lower in the FNB group (2 vs. 3, p<0.001), and the histological yield was higher (92.9% vs. 84.5%, p=0.019). The needle type was not independently associated with diagnostic accuracy (OR 1.76, 95% CI 0.69-4.52; p=0.24). In lesions measuring ≤10 mm, subgroup analysis was limited by the small sample size of the study. The rarly adverse event rates were low in both groups. Conclusion In pancreatic solid lesions ≤20 mm, FNB showed a higher histological yield and required fewer needle passes, whereas no significant difference in the diagnostic accuracy was observed between FNA and FNB. Therefore, the routine replacement of FNA with FNB may not be justified when benign-malignant differentiation is sufficient. FNB may be preferable when histological architecture or immunohistochemical evaluation is required and is considered technically feasible.
SN - 1349-7235
SN - 0918-2918
ER -